These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 25517863)

  • 1. Omics meets biology: application to the design and preclinical assessment of antivenoms.
    Calvete JJ; Sanz L; Pla D; Lomonte B; Gutiérrez JM
    Toxins (Basel); 2014 Dec; 6(12):3388-405. PubMed ID: 25517863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxin-resolved antivenomics-guided assessment of the immunorecognition landscape of antivenoms.
    Calvete JJ; Rodríguez Y; Quesada-Bernat S; Pla D
    Toxicon; 2018 Jun; 148():107-122. PubMed ID: 29704534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ending the drought: new strategies for improving the flow of affordable, effective antivenoms in Asia and Africa.
    Williams DJ; Gutiérrez JM; Calvete JJ; Wüster W; Ratanabanangkoon K; Paiva O; Brown NI; Casewell NR; Harrison RA; Rowley PD; O'Shea M; Jensen SD; Winkel KD; Warrell DA
    J Proteomics; 2011 Aug; 74(9):1735-67. PubMed ID: 21640209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Snake venomics and antivenomics: Proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming.
    Gutiérrez JM; Lomonte B; León G; Alape-Girón A; Flores-Díaz M; Sanz L; Angulo Y; Calvete JJ
    J Proteomics; 2009 Mar; 72(2):165-82. PubMed ID: 19344652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological profile of antivenoms: preclinical analysis of the efficacy of a polyspecific antivenom through antivenomics and neutralization assays.
    Gutiérrez JM; Lomonte B; Sanz L; Calvete JJ; Pla D
    J Proteomics; 2014 Jun; 105():340-50. PubMed ID: 24583507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antivenomics and in vivo preclinical efficacy of six Latin American antivenoms towards south-western Colombian Bothrops asper lineage venoms.
    Mora-Obando D; Pla D; Lomonte B; Guerrero-Vargas JA; Ayerbe S; Calvete JJ
    PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009073. PubMed ID: 33524033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa.
    Harrison RA; Oluoch GO; Ainsworth S; Alsolaiss J; Bolton F; Arias AS; Gutiérrez JM; Rowley P; Kalya S; Ozwara H; Casewell NR
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005969. PubMed ID: 29045429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical Evaluation of the Efficacy of Antivenoms for Snakebite Envenoming: State-of-the-Art and Challenges Ahead.
    Gutiérrez JM; Solano G; Pla D; Herrera M; Segura Á; Vargas M; Villalta M; Sánchez A; Sanz L; Lomonte B; León G; Calvete JJ
    Toxins (Basel); 2017 May; 9(5):. PubMed ID: 28505100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing the impact of snakebite envenoming in Latin America and the Caribbean: achievements and challenges ahead.
    Gutiérrez JM
    Trans R Soc Trop Med Hyg; 2014 Sep; 108(9):530-7. PubMed ID: 25096295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The medical threat of mamba envenoming in sub-Saharan Africa revealed by genus-wide analysis of venom composition, toxicity and antivenomics profiling of available antivenoms.
    Ainsworth S; Petras D; Engmark M; Süssmuth RD; Whiteley G; Albulescu LO; Kazandjian TD; Wagstaff SC; Rowley P; Wüster W; Dorrestein PC; Arias AS; Gutiérrez JM; Harrison RA; Casewell NR; Calvete JJ
    J Proteomics; 2018 Feb; 172():173-189. PubMed ID: 28843532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of three polyspecific antivenoms against the venom of Echis ocellatus: Neutralization of toxic activities and antivenomics.
    Calvete JJ; Arias AS; Rodríguez Y; Quesada-Bernat S; Sánchez LV; Chippaux JP; Pla D; Gutiérrez JM
    Toxicon; 2016 Sep; 119():280-8. PubMed ID: 27377229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Review of the Proteomic Profiling of African Viperidae and Elapidae Snake Venoms and Their Antivenom Neutralisation.
    Offor BC; Muller B; Piater LA
    Toxins (Basel); 2022 Oct; 14(11):. PubMed ID: 36355973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the preclinical efficacy of four antivenoms, distributed in sub-Saharan Africa, to neutralize the venom of the carpet viper, Echis ocellatus, from Mali, Cameroon, and Nigeria.
    Sánchez LV; Pla D; Herrera M; Chippaux JP; Calvete JJ; Gutiérrez JM
    Toxicon; 2015 Nov; 106():97-107. PubMed ID: 26415904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of preclinical efficacy testing of antivenoms for sub-Saharan Africa: Inadequate independent scrutiny and poor-quality reporting are barriers to improving snakebite treatment and management.
    Ainsworth S; Menzies SK; Casewell NR; Harrison RA
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008579. PubMed ID: 32817682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical efficacy of Australian antivenoms against the venom of the small-eyed snake, Micropechis ikaheka, from Papua New Guinea: an antivenomics and neutralization study.
    Pla D; Paiva OK; Sanz L; Beutler M; Wright CE; Calvete JJ; Williams DJ; Gutiérrez JM
    J Proteomics; 2014 Oct; 110():198-208. PubMed ID: 24980637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Fangs to Pharmacology: The Future of Snakebite Envenoming Therapy.
    Laustsen AH; Engmark M; Milbo C; Johannesen J; Lomonte B; Gutiérrez JM; Lohse B
    Curr Pharm Des; 2016; 22(34):5270-5293. PubMed ID: 27339430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing the Cross-Neutralisation Potential of Existing Antivenoms for Mitigating the Outcomes of Snakebite in Sub-Saharan Africa.
    Khochare S; Jaglan A; Rashmi U; Dam P; Sunagar K
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new Pan African polyspecific antivenom developed in response to the antivenom crisis in Africa.
    Laing GD; Renjifo JM; Ruiz F; Harrison RA; Nasidi A; Gutierrez JM; Rowley PD; Warrell DA; Theakston RD
    Toxicon; 2003 Jul; 42(1):35-41. PubMed ID: 12893059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venomics of the poorly studied hognosed pitvipers Porthidium arcosae and Porthidium volcanicum.
    Ruiz-Campos M; Sanz L; Bonilla F; Sasa M; Lomonte B; Zaruma-Torres F; Terán M; Fernández J; Calvete JJ; Caldeira CAS; Da Silva SL
    J Proteomics; 2021 Oct; 249():104379. PubMed ID: 34534714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the preclinical efficacy of antivenoms: from the lethality neutralization assay to antivenomics.
    Gutiérrez JM; Solano G; Pla D; Herrera M; Segura Á; Villalta M; Vargas M; Sanz L; Lomonte B; Calvete JJ; León G
    Toxicon; 2013 Jul; 69():168-79. PubMed ID: 23201503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.